Simpirica Spine, Inc. was founded in 2006 to develop minimally invasive, flexion-restricting stabilization devices.

The potential for this novel stabilization approach is tremendous. Flexion, or forward bending, of the lumbar spine can lead to pain or instability for over 400,000 patients per year worldwide.

Outside the U.S., the company's lead product, the LimiFlex Spinal Stabilization System, has a CE Mark and is approved for distribution in the European Union, where it is typically used in conjunction with a surgical decompression for the treatment of lumbar spinal stenosis with or without degenerative spondylolisthesis.

In the U.S., safety and effectiveness of the LimiFlex Spinal Stabilization System will be evaluated in a randomized study in which patients will undergo surgical decompression followed by stabilization with either the LimiFlex Device or fusion for the treatment of lumbar spinal stenosis with degenerative spondylolisthesis.

The Simpirica team is dedicated to fulfilling the promise of flexion-restricting stabilization and to improving clinical outcomes for patients and surgeons around the globe.

United States: CAUTION - Investigational device. Limited by United States law to investigational use.